SCI Ventures, launched with $27 million, will invest in companies developing new therapies and technologies to treat spinal cord injuries and paralysis. Spearheading the effort is the Christopher & Dana Reeve Foundation.
Read MoreAs the field advances at a quick clip, the Dana Foundation, Kavli Foundation and the late Paul Allen’s philanthropic vehicles are all pursuing ways to push neuroscience into new, cross-disciplinary territory.
Read MoreA year after their son died as a result of complications from neurofibromatosis, mortgage lending billionaire Dan Gilbert and his wife Jennifer continue to plow research dollars into the incurable genetic disorder.
Read MoreGary Payton II of the NBA’s Golden State Warriors is bringing his platform to bear on dyslexia, which he struggled with as a child. We connected with Payton and his mother and sister, leaders of his foundation, to learn more.
Read MoreThe Dana Foundation has been a key backer of neuroscience research for four decades. But as the field increasingly impacts broader society, the foundation wants to ensure that the science steers toward the public good.
Read MoreThe neurodegenerative disease gets less funder attention than other more common conditions, which is why a set of new $1 million research grants from the Hereditary Disease Foundation could really move the needle.
Read MoreAligning Science Across Parkinson's, established by the Google cofounder, wants to diversify genetic research into the neurodegenerative disease. Its latest big grant will expand the geographic scope of a key international study.
Read MoreOne unique feature of the Chan Zuckerberg Initiative is that it not only funds biomedical research, it employs a team of specialists to build new technology that can accelerate that research. Here’s how it works.
Read MoreThe Allen Institute and Chan Zuckerberg Initiative teamed up with the University of Washington to pioneer a new generation of research tools with the ability to record the life and times of individual human cells.
Read MorePsychedelics show great promise in a range of medical therapies, but legal constraints and stigma have kept public funding minimal. As a result, philanthropy remains crucial to advancing research. Here’s the latest gift.
Read MoreShari and Garen Staglin’s son Brandon began showing symptoms of schizophrenia as a teen. Today, he’s president of One Mind, which backs mental health, and the family is raising serious funds for research and more.
Read MoreThe Larry L. Hillblom Foundation funds research to cure diabetes and the degenerative diseases of aging. It was founded after the death of its eponymous original donor, about whom disturbing revelations emerged.
Read MoreThe Lauder family, with wealth from the cosmetics dynasty, is a top supporter of Alzheimer's research. We take a closer look at a recent $200 million commitment for drug development and philanthropy’s role in the field.
Read MoreThe Chan Zuckerberg Initiative is backing an effort to diversify the neuroscience field and the people participating in research on brain disorders. Is more such funding on the way?
Read MoreWe recently published an in-depth paper on trends in neuroscience research funding as part of IP’s State of American Philanthropy project. Author Mike Scutari takes a look at some of the report’s key findings.
Read MoreOver 25 million Americans live with rare diseases, and 90% of rare diseases do not have an FDA-approved treatment. We look at how the National Organization for Rare Disorders is moving the needle in this evolving field.
Read MoreThe Chicago-based Muscular Dystrophy Association is a leading funder in the field of neuromuscular diseases. We check in with Chief Research Officer Dr. Sharon Hesterlee to discuss current challenges and priorities.
Read MoreMillions will experience the effects of cognitive decline without being diagnosed with a neurological disease. Two prominent funders of cognitive aging research share how they are working to overcome this challenge.
Read MoreCURE Epilepsy funds research to cure and more effectively treat a neurological condition that affects 3.4 million Americans. Part of that mission involves ending the silence that still surrounds epilepsy.
Read MoreThe FDA recently approved a new drug to treat ALS. Here’s how the ALS Association, equipped with funding from 2014’s viral Ice Bucket Challenge, contributed to that outcome — and what it’s looking to do next.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
